CERo Therapeutics Holdings Financial Ratios for Analysis 2021-2024 | CERO

Fifteen years of historical annual and quarterly financial ratios and margins for CERo Therapeutics Holdings (CERO).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202320222021
1.651.3813.88
---
-0.11-0.06-
---
---
---
---
---
---
---
---
---
---
17.866.074.11
17.866.074.11
-29.63-1.58-0.18
17.866.074.11
-2.59-2.01-1.40
-0.66-0.24-0.15
-0.66-0.24-0.15

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
0.390.480.470.561.763.204.381.380.903.616.28-0.09
-------------
-0.03-0.10-0.10-0.01-0.10-0.09-0.06-0.06-----
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
58.0420.5417.14-7.959.8015.7421.062.39-0.931.374.70--
11498.6657.79-7.959.8015.7421.062.39-0.931.374.70--
-65.13-33.22-25.4065.23-15.93-14.83-16.90-0.620.05-0.06-0.21--
11498.6657.79-7.959.8015.7421.062.39-0.931.374.70--
-0.03-0.11-0.27-4.64-2.51-2.43-2.11-2.01-1.65-1.49-1.47-0.01
-0.23-0.53-0.36-0.66-0.53-0.39-0.16-0.24-0.16-0.12-0.070.000.00
-0.23-0.53-0.36-0.66-0.53-0.39-0.16-0.24-0.16-0.12-0.07--